Starting on:
Mar 22, 2022
Ending on:
Apr 20, 2022
Moderator(s):
Venue:
Virtual-ICI
Max Credits:
10 Points
Provider:
International Cancer Institute
Claim Points
Mar 22, 2022
Ending on:
Apr 20, 2022
Moderator(s):
Virtual-ICI
Max Credits:
10 Points
Provider:
International Cancer Institute
Claim Points
Prostate Cancer Preceptorship
Starting on:
Mar 22, 2022 4:00 PM
Mar 22, 2022 4:00 PM
Ending on:
Apr 20, 2022 5:30 PM
Apr 20, 2022 5:30 PM
Venue:
Virtual-ICI
Virtual-ICI
Description
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development
Objectives
At the end of this educational activity, participants should be able to:
1. Understand the Epidemiology of Prostate Cancer (Global)
2. To understand the role of screening for prostate cancer, including the evidence for and against the
use of prostate-specific antigen (PSA) screening and the practical indications of serum PSA
measurement in different clinical settings
3. recognize the role of pathological diagnosis, histologic grading, Gleason system, staging and
prognostic factors in prostate cancer.
4. To understand the role of Surgery in the management of localized prostate cancer
5. To understand the role of radiotherapy in the management of localized prostate cancer
6. understand the management options for hormone-sensitive metastatic prostate cancer
7. To understand the definition of castration-resistant prostate cancer (CRPC) and appreciate the novel
therapies, their use, and side effects profile in m-CRPC.
8. Discuss treatment options for patients with advanced prostate cancer, including secondary
hormonal therapy, chemotherapy, immunotherapy, and radioisotope therapy
9. Understanding of how and when to use bone-targeted therapies and of the prevention and treatment
of osteonecrosis of the jaw
10. To understand the role of the multidisciplinary team in prostate cancer management
11. To understand the role of Palliative, supportive, and survivorship care in prostate cancer
management
12. Ability to diagnose and manage spinal cord compression, one of the most devastating complications
of metastatic prostate cancer
13. To discuss clinical cases between faculty and participants
Presenters
-
Dr.
Achille Manirakiza
Clinical Oncologist
Rwanda Military Hospital Radiation Therapy Center & King Faisal Hospital -
Dr.
Sitna Mwanzi
Medical Oncologist
Aga Khan University Hospital -
Dr.
Kibet Kibor
Anatomic Pathologist
Moi Teaching and Referral Hospital -
Dr.
Irene Weru
Oncology Pharmacist
Kenyatta National Hospital -
Prof.
Dinesh Pendarkhar
Medical Oncologist
Sarvodaya Hospital Faridabad,Delhi -
Dr.
Verna Vanderpuye
Radiation Oncologist
National Center for Radiotherapy Oncology and Nuclear Medicine Korle Bu Teaching Hospital, Accra- Ghana -
Dr.
Abdu Adem
Clinical Oncologist
St. Paul's Millennium Hospital, Ethiopia -
Dr.
Achille Manirakiza
Clinical Oncologist
Rwanda Military Hospital Radiation Therapy Center & King Faisal Hospital -
Dr.
Helena Musau
Clinical Oncologist
Meru Teaching and Referral Hospital -
Dr.
Kevin Makori
Clinical and Radiation Oncologist
International Cancer Institute -
Dr.
Zipporah Ali
Palliative Care Specialist
Kenya Palliative & Hospices Center -
Prof.
Fredrick Chite
Consultant Physician. Chief Medical Oncologist & Hematologist Executive Director/ CEO
International Cancer Institute